SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-05-000398
Filing Date
2005-04-21
Accepted
2005-04-21 14:18:03
Documents
3
Group Members
WARBURG PINCUS & CO.WARBURG PINCUS LLC (F/K/A E.M. WARBURG PINCUS & CO., LLC)WARBURG PINCUS PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 w2838814a.txt SC 13D/A 22377
2 VOTING AGREEMENT w2838814b.txt EX-1 20049
3 AMENDED AND RESTATED JOINT FILING AGREEMENT w2838814c.txt EX-2 2933
  Complete submission text file 0000899140-05-000398.txt   47207
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47221 | Film No.: 05764312
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 466 LEXINGTON AVE. NEW YORK NY 10017 2128780600
WARBURG PINCUS EQUITY PARTNERS LP (Filed by) CIK: 0001075598 (see all company filings)

Type: SC 13D/A